Stephania Libreros, PhD

Dr. Stephania Libreros' lab focuses on uncovering the biochemical, immunological, and molecular mechanisms that restore organ-specific and systemic homeostasis following pathological challenges, and understanding why these mechanisms sometimes fail, leading to chronic inflammation. Her goal is to identify novel pro-resolving mediators and circuits that enhance host protection, promote microbial clearance, and facilitate tissue regeneration in humans.

Dr. Libreros earned her Ph.D. in Immunology, where she studied how pre-existing inflammation drives tumor metastasis and myeloid-induced inflammation. She then completed her postdoctoral fellowship at Harvard University with Professor Charles N. Serhan, working on the structural elucidation of novel molecules and networks that control the resolution of inflammation. Her research explored how these pathways could lead to a new class of therapeutics by harnessing the body's natural ability to resolve inflammation. She has received multiple scientific awards, including the the Eicosanoid Research Foundation Santosh Nigam Outstanding Young Scientist Award, the Early Career Investigator Award from the Society for Leukocyte Biology, and the NIH Pathway to Independence Award (K99/R00).

Dr. Libreros is constant advocator for Diversity, Equity, and Inclusion (DEI) in biomedical Science, where she fosters an inclusive environment and promotes equity as a key driver for innovation and scientific progression.